News

Rajesh Shrotriya, chairman, president and CEO of Spectrum, said: “The sale of these non-core assets provides additional non-dilutive funding which will be used to further fund the advancement

With this acquisition, Enzo Life Sciences now has US operations in New York, Pennsylvania and California, and overseas facilities in Switzerland, the UK and Belgium, as well as

Warner Chilcott’s Dovonex is indicated for the topical treatment of psoriasis of the scalp. Hi-Tech will pay Warner Chilcott a portion of the profits from the sale of

Mr Beck joins Ardea Biosciences from Metabasis Therapeutics, which he co-founded in 1999 and where he served most recently as senior vice president of finance, CFO and treasurer.

Increasing the accrual period allowed decreasing the total number of patients in the study, without changing the required statistical analyses. As a result, the Ovature study will enroll

Exactech has offered the shares pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. The offering is expected to close on or before

This comes on the heels of the Patent Office’s decision in April, 2008 to allow Vnus a separate patent application, also filed as a continuation of one of

This notice of no objection allows for the initiation of human clinical studies in Canada. The first Phase I clinical trial will assess the safety of PMX-30063. The

Mr Jackson joined Celator in October 2007 as head of commercial development. Mr Jackson has extensive experience in the pharmaceutical and biotechnology industry and has held positions of